美国食品和药物管理局在2026年2月推出了一项新的食品安全数据工具,以帮助提高透明度,推动食品行业因GLP-1药物而发生变化. The FDA launched a new food safety data tool in Feb 2026, aiding transparency and driving food industry changes due to GLP-1 drugs.

林业发展局于2026年2月启用了TDSi网络工具,扩大了获得数十年关于营养物和污染物的食品安全数据的途径,有助于透明度和决策。 The FDA launched the TDSi web tool in February 2026, offering expanded access to decades of food safety data on nutrients and contaminants, aiding transparency and decision-making. 它已经被用来反驳佛罗里达州关于糖果中的砷的主张,工业集团引用了更准确的风险评估。 It has already been used to dispute Florida’s claims about arsenic in candy, with industry groups citing more accurate risk assessments. 同时,GLP-1减重药物正在推动食品和饮料市场发生重大变化,促使重整和新的产品战略侧重于低糖和低卡路里。 Meanwhile, GLP-1 weight-loss drugs are driving major shifts in food and beverage markets, prompting reformulations and new product strategies focused on lower sugar and calories. 这些变化正在加速功能性食品和清洁标签食品的创新。 These changes are accelerating innovation in functional and clean-label foods. 未来食品技术公司旧金山分会定于2026年3月进行,将探讨这些趋势,突出发酵、AI和可持续粮食系统方面的进展。 Future Food-Tech San Francisco, scheduled for March 2026, will explore these trends, highlighting advances in fermentation, AI, and sustainable food systems.